Medicina Legal, Psiquiatría y Patología
Fachbereich
Leeds and York Partnership NHS Foundation Trust
Leeds, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Leeds and York Partnership NHS Foundation Trust (12)
2020
-
Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use
Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529
-
Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia – data from the OPTiMiSE trial
Psychiatry Research, Vol. 289
-
The identification, assessment and management of difficult-to-treat depression: An international consensus statement
Journal of Affective Disorders, Vol. 267, pp. 264-282
2019
-
Distinct associations between fronto-striatal glutamate concentrations and callous-unemotional traits and proactive aggression in disruptive behavior
Cortex, Vol. 121, pp. 135-146
-
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436
-
Transdiagnostic dimensions of psychopathology at first episode psychosis: Findings from the multinational EU-GEI study
Psychological Medicine, Vol. 49, Núm. 8, pp. 1378-1391
2018
-
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study
The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807
2017
-
The association between comorbid autism spectrum disorders and antipsychotic treatment failure in early-onset psychosis: A historical cohort study using electronic health records
Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. e1233-e1241
2016
-
Autism spectrum disorder and schizophrenia: Boundaries and uncertainties
BJ Psych Advances, Vol. 22, Núm. 5, pp. 316-324
-
BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents
Journal of Psychopharmacology, Vol. 30, Núm. 5, pp. 416-421
2015
-
Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: A review of current evidence and directions for future research
Schizophrenia Bulletin, Vol. 41, Núm. 3, pp. 574-583
2014
-
Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114